80
Participants
Start Date
May 29, 2018
Primary Completion Date
May 1, 2020
Study Completion Date
May 28, 2020
Pentetrazol (PTZ)
BTD-001 is an oral capsule of PTZ.
Placebo oral capsule
Placebo will be presented as oral capsule.
Columbia University - Department of Neurology, New York
Albert Einstein College of Medicine, New York
Consolidated Clinical Trials, Monroeville
Geisinger, Danville
The Center for Sleep and Wake Disorders, Chevy Chase
Research Carolina of Huntersville, Huntersville
Bogan Sleep Consultants, LLC, Columbia
NeuroTrials Research Inc., Atlanta
Sleep Practicioners, Macon
Florida Premier Research Institute, Winter Park
Sleep Medicine Specialists of South Florida, Miami
PAB Clinical Research, Brandon
Sleep Disorders Center of Alabama, Birmingham
Kentucky Research Group, Louisville
Fort Wayne Neurology, Fort Wayne
Sleep and Attention Disorders Institute, Sterling Heights
Neuroscience Center, Saint Paul
Northshore Sleep Medicine, Northbrook
St. Luke's Sleep Medicine and Research Center, Chesterfield
Rowe Neurology Institute, Lenexa
Lynn Health Science Institute, Oklahoma City
Houston Sleep Center, Houston
Future Search Trials, Austin
REM Sleep Medicine, Boulder
Mayo Clinic Hospital, Scottsdale
Santa Monica Clinical Trials, Santa Monica
Pacific Research Network, San Diego
SDS Clinical Trials, Orange
Sleep Medicine Specialists of California, San Ramon
Intrepid Research, Cincinnati
Swedish Medical Center, Seattle
NeuroCare, Newton
Lead Sponsor
Balance Therapeutics
INDUSTRY